EPISODE · Sep 16, 2022 · 30 MIN
Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs
from Investors' Chronicle
On this week's Companies and Markets show, the team discuss a reality check for hydrogen hope ITM Power (ITM), whose annual results sparked a steep sell-off in the company’s shares on Wednesday.Economics writer Hermione Taylor then outlines the debate over ‘Trussonomics’, looking at government policies and their potential impact on the UK economy, sterling, and the gilt market.Last but not least, Jennifer Johnson runs the rule over latest figures from Advanced Medical Solutions (AMS) and Abcam (ABC), as well as the latter’s plans to delist from Aim.Dan Jones hosts Julian Hofmann, Hermione Taylor, Jennifer Johnson and Alex Newman.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
Ready to play
Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs
No transcript for this episode yet
Similar Episodes
No similar episodes found.